CTOs on the Move

Zynex Medical

www.zynexmed.com

 
Zynex, founded in 1996, operates under five primary business segments: Zynex Medical, NeuroDiagnostics, Monitoring Solutions, International, and Billing and Consulting. Zynex Medical engineers, manufactures, markets and sells its own design of electrotherapy medical devices used for pain management and rehabilitation; and the company's proprietary NeuroMove device designed to help recovery of stroke and spinal cord injury patients. Zynex Medical's product lines are fully developed, FDA-cleared and commercially sold world-wide. Zynex Medical also operates a non-sterile compound pharmacy providing topical and transdermal pain creams. Zynex NeuroDiagnostics sells and distributes EMG, EEG, sleep pattern, auditory and nerve conductivity neurological devices. Zynex Monitoring ...
  • Number of Employees: 25-100
  • Annual Revenue: $10-50 Million
  • www.zynexmed.com
  • 9990 Park Meadows Dr
    Lone Tree, CO USA 80124
  • Phone: 800.495.6670

Executives

Name Title Contact Details

Similar Companies

Marus Dental International

Marus Dental International is a Charlotte, NC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

SurePoint Medical

SurePoint Medical is a Lawrence, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

PhiloMetron Inc

PhiloMetron Inc is a San Diego, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

National Center For Homeopathy

National Center For Homeopathy is a Alexandria, VA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

TranS1

Restructured under new ownership in 2015, TranS1 has emerged stronger than ever – ready to support a product line that provides a foundation for living well, driven by surgeon innovation. Our impressive team includes experienced R&D, Sales and Professional Education professionals. The TranS1 team is focused on resilient and continuous training of its sales force and physician customers, employing best in class training methods that ultimately benefit patients.